2 February 2023 | Organisers: GENDRO and CIOMS
GENDRO and CIOMS jointly convened a meeting with key stakeholders, including the World Medical Association, Council of Europe, World Health Organization, representatives from research ethics committees, research institutions, and the pharmaceutical industry. The focus was on the crucial role of Research Ethics Committees (RECs) in addressing gender bias in research with human participants, using the SAGER guidelines as a valuable tool. CIOMS’ Secretary General Dr. Lembit Rägo initiated a dialogue on the role of RECs in strengthening sex and gender considerations in health research. GENDRO’s President, Dr. Shirin Heidari, underscored the concern of inadequate incorporation of sex and gender considerations in research and credited the success of the SAGER guidelines in raising awareness and improving reporting. Emphasizing the responsibility of every gatekeeper in the research ecosystem, including RECs, Dr. Heidari stressed the need for proper integration of sex and gender considerations throughout health research.
Dr. Abha Saxena, an independent bioethicist, presented findings from a scoping review conducted as part of GENDRO’s working group on gender and research ethics, revealing a lack of evidence on sufficient attention to sex and gender dimensions in the work of RECs.
The meeting facilitated consensus-building on the importance of a unified approach among all stakeholders in the research ecosystem to enhance the inclusion and meaningful consideration of sex and gender in research. The meeting concluded with proposed actions and a collaborative path forward, committed to by GENDRO and CIOMS.
Read the full report here.